Berberine and Blood Sugar: Major Meta-Analysis Results
Berberine is a natural alkaloid found in several plants, including barberry (Berberis). It has been used in traditional Chinese medicine and Ayurveda for thousands of years. Over the past decade, scientific research has brought berberine into the spotlight for its potential metabolic effects — particularly regarding blood sugar regulation.
Liang et al. 2019: Extensive Meta-Analysis
One of the most important works on berberine's blood sugar effects is the meta-analysis by Liang et al. (2019), which compiled:
- 28 randomised controlled trials (RCTs)
- Over 2,000 participants
- A geographically and demographically diverse sample
Key results:
- Berberine significantly reduced fasting blood glucose levels
- HbA1c (glycated haemoglobin) values also improved
- Lipid profile (cholesterol, triglycerides) showed improvement as well
- Results were consistent across different studies
Yin et al. 2008: Pilot Study
An earlier important study by Yin et al. (2008) also showed promising results:
- In a pilot study, berberine demonstrated comparable glucose-lowering effects
- Lipid levels also improved
- The study had a small sample, meaning results are preliminary
Important emphasis: This was a small-scale pilot study and results should not be over-interpreted. Larger confirmatory studies are needed.
AMPK: Berberine's Primary Mechanism
Scientists have identified berberine's primary mechanism of action: AMPK (AMP-activated protein kinase) activation (Lee et al., 2006).
AMPK is an enzyme often called the body's "metabolic master switch." Its activation:
- Increases glucose uptake into cells
- Improves insulin sensitivity
- Promotes fatty acid oxidation (fat burning)
- Activates multiple cellular energy-related pathways
This is the same pathway activated by physical exercise and certain pharmaceutical products. Berberine influences this pathway as a natural compound.
Important: What Berberine Is NOT
One of the most critical points to emphasise:
- Berberine is not a medicine for treating diabetes
- It does not replace physician-prescribed medications
- Berberine should not be used as a replacement for existing medication without medical approval
- Study results are promising but insufficient for making medical claims
EFSA has not approved any health claims for berberine. All data presented here represents research findings, not regulatory approved health claims.
If you have blood sugar concerns, always consult your doctor before using any supplement.
How Berberine Works: A Closer Look
Beyond AMPK, berberine's action involves several other mechanisms:
Gut Microbiome Modulation
- Berberine influences gut bacteria composition (Zhang et al., 2012)
- The gut microbiome is increasingly considered a mediator of metabolic processes
- This is one reason berberine has low oral bioavailability (~5%) yet still shows noticeable effects
Insulin Sensitivity
- Berberine may support insulin receptor expression
- This contributes to more efficient glucose uptake into cells
Hepatic Gluconeogenesis
- Berberine may reduce the liver's glucose production
- This is one mechanism through which fasting blood sugar decreases
Dosing
Typical doses used in studies:
- 500mg 2–3 times daily with meals
- Total of 1,000–1,500mg daily
- Starting with a lower dose (500mg/day) and gradually increasing
- Taking with meals is important — for both bioavailability and digestive tolerance
Several berberine products are available in Estonia, such as the budget-friendly OstroVit Berberine 90tabs (€9.90), VitalHarmony Berberine 500mg 90caps (€11.90), or the higher-dose NOW Berberine Glucose support 90caps (€36.90). If you also strength train, the creatine category is worth a look for basic strength support — see also our berberine myths and facts article and the dosage and safety guidelines.
Side Effects and Risks
Berberine is generally well-tolerated, but important considerations exist:
Gastrointestinal Discomfort
- Most common side effect: cramping, nausea, diarrhoea
- Usually resolves within a few weeks
- Starting with a low dose reduces GI issues
Drug Interactions
- Berberine affects CYP enzymes (especially CYP3A4, CYP2D6)
- This can alter the metabolism and effects of many medications
- Mandatory: consult your doctor if you take any medications
Contraindications
- During pregnancy, berberine is contraindicated
- During breastfeeding, insufficient safety data exists
- People with low blood sugar should be especially cautious
Where Berberine Comes From
Berberine is an alkaloid found in several plants:
- Berberis (barberry) — primary source
- Coptis chinensis (Chinese goldthread)
- Hydrastis canadensis (goldenseal)
- Phellodendron amurense (Amur cork tree)
Supplements typically use berberine hydrochloride (berberine HCL), a standardised form.
If you also want to cover protein needs alongside berberine, a product from the proteins category pairs well — our berberine forms comparison can help you pick the right form.
Summary
- Liang et al. (2019) meta-analysis (28 RCTs, 2,000+ participants): berberine significantly reduced fasting blood glucose
- Yin et al. (2008): promising preliminary results in a small pilot study
- Primary mechanism: AMPK activation
- Berberine is not a diabetes medication and does not replace medical advice
- EFSA has not approved health claims for berberine
- Typical dose: 500mg 2–3× daily with meals
- Main side effects: GI discomfort (usually temporary)
- Always consult your doctor, especially if taking medications
Dietary supplements are not a substitute for a varied, balanced diet and healthy lifestyle.
Browse our berberine selection at MaxFit.ee →
References
- Liang Y, Xu X, Yin M, Zhang Y, Huang L, Chen R, Ni J. (2019). Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis. Endocrine Journal, 66(1), 51-63. https://pubmed.ncbi.nlm.nih.gov/30393248/
- Yin J, Xing H, Ye J. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism, 57(5), 712-717. https://pubmed.ncbi.nlm.nih.gov/18442638/
- Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye JM, Lee CH, Oh WK, Kim CT, Hohnen-Behrens C, Gosby A, Kraegen EW, James DE, Kim JB. (2006). Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes, 55(8), 2256-2264. https://pubmed.ncbi.nlm.nih.gov/16873688/
- Zhang X, Zhao Y, Zhang M, Pang X, Xu J, Kang C, Li M, Zhang C, Zhang Z, Zhang Y, Li X, Ning G, Zhao L. (2012). Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One, 7(8), e42529. https://pubmed.ncbi.nlm.nih.gov/22880019/
